We’re excited to announce our strategic investment into Corilus, a leader in medical software solutions for the primary care market in Belgium. Corilus helps enable a smart and efficient healthcare system by connecting care providers, patients and stakeholders, with its cloud-based connected care solutions already used by over 30,000 care providers including general practitioners, dentists, hospitals, labs and others throughout the industry. “Under the leadership of Dirk Van Lerberghe alongside Rivean Capital, Corilus has established its position as a leading medical software solutions provider with an impressive offering and client base. We are excited to combine our expertise growing international software champions with Corilus’ talented team to support the expansion of product offerings and functionality, including through the potential of GenAI solutions to assist practitioners and entering new markets. We see great potential for continued growth through innovation as we seek to accelerate Corilus’ mission to develop a smart and efficient healthcare system,” said Dany Rammal, Managing Director and Head of Europe at PSG. Learn more about our partnership here: https://lnkd.in/eWBnw8c5 #software #growthequity
Congratulations to PSG and Corilus on this deal. The combination of PSG's PEI expertise in international software growth and Corilus' strong market presence promises significant value creation. #GenAI in healthcare? Magical!!! I'm excited, what's next!
Cheers and Congratulations!! 🎉